Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5401 to 5415 of 7681 results

  1. Clinical epidemiology of Lyme disease in the UK:- What are the incidence, presenting features, management and outcome of Lyme disease in the UK?

    Recommendation ID NG95/2 Question Clinical epidemiology of Lyme disease in the UK:- What are the incidence, presenting features, management

  2. Neoadjuvant treatment:- What are the indications for postmastectomy radiotherapy after neoadjuvant chemotherapy?

    Recommendation ID NG101/6 Question Neoadjuvant treatment:- What are the indications for postmastectomy radiotherapy after neoadjuvant chemotherapy

  3. Indicator conditions:- What is the UK prevalence of HIV in various indicator conditions, and how effective are interventions using indicator condition-targeted testing compared with other testing strategies?

    Recommendation ID NG60/4 Question Indicator conditions:- What is the UK prevalence of HIV in various indicator conditions, and how effective

  4. Frequency and duration of endoscopic surveillance: What is the usefulness of clinical and molecular biomarkers to inform the optimal frequency and duration of endoscopic surveillance for adults with Barrett's oesophagus?

    Recommendation ID NG231/02 Question Frequency and duration of endoscopic surveillance: What is the usefulness of clinical and molecular

  5. Risk stratification tool to estimate risk of recurrence: What is the utility of a risk stratification tool to estimate the risk of subsequent aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/05 Question Risk stratification tool to estimate risk of recurrence: What is the utility of a risk stratification

  6. Personalisation and risk markers:- What prognostic and prescriptive factors are important in determining the choice of PTSD treatment?

    Recommendation ID NG116/4 Question Personalisation and risk markers:- What prognostic and prescriptive factors are important in determining

  7. What proportion of people with melanoma who are referred into secondary care under the 2 week wait rule, have equivocal moles that are excised and have equivocal moles that are monitored?

    Recommendation ID DG19/2 Question What proportion of people with melanoma who are referred into secondary care under the 2 week wait rule

  8. Carbon monoxide monitoring: What is the validity of different thresholds of carbon monoxide in exhaled breath as markers of quitting, based on diagnostic review and modelling?

    Recommendation ID NG209/13 Question Carbon monoxide monitoring: What is the validity of different thresholds of carbon monoxide in exhaled

  9. What is the value of a key worker approach (defined by protocol and delivered in addition to usual care) for autistic children and young people in terms of parental satisfaction, functioning and stress and child psychopathology?

    Recommendation ID CG170/1 Question What is the value of a key worker approach (defined by protocol and delivered in addition to usual care)

  10. What proxy outcome measures are suitable for studies of the primary prevention of skin cancer?

    Recommendation ID PH32/4 Question What proxy outcome measures are suitable for studies of the primary prevention of skin cancer? Any

  11. Factors that may be barriers to successfully managing chronic pain, including chronic primary pain: What risk factors enable stratification of treatment for people aged 16 years and over with chronic pain?

    Recommendation ID NG193/6 Question Factors that may be barriers to successfully managing chronic pain, including chronic primary pain:

  12. What risk factors in people who are critically ill and have, or have had, COVID-19 as part of their acute illness are associated with developing COVID-19-associated pulmonary aspergillosis (CAPA)?

    Recommendation ID NG191/10 Question What risk factors in people who are critically ill and have, or have had, COVID-19 as part of their

  13. What key factors influence differences in walking and cycling behaviour among different groups – and what are the implications for interventions aiming to achieve population-level change and reduce inequalities?

    Recommendation ID PH41/5 Question What key factors influence differences in walking and cycling behaviour among different groups – and

  14. What key factors influence the effectiveness of population-level or whole-area approaches to encouraging walking or cycling? How do these factors interact?

    Recommendation ID PH41/2 Question What key factors influence the effectiveness of population-level or whole-area approaches to encouraging